MedAvail Holdings, Inc. (MDVLQ) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cotizando a $, MedAvail Holdings, Inc. (MDVLQ) es una empresa del sector Healthcare valorada en 0. La acción obtiene una puntuación de 50/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 16 mar 2026MedAvail Holdings, Inc. (MDVLQ) Resumen de Asistencia Médica y Tuberías
MedAvail Holdings, Inc. was a technology-driven retail pharmacy company offering self-service kiosk solutions and mobile applications in the United States and Canada. Focused on onsite prescription dispensing via its MedAvail MedCenter, the company connected patients with pharmacists remotely. MedAvail filed for Chapter 7 liquidation in early 2024.
Tesis de Inversión
MedAvail Holdings, Inc. presented an investment case centered on its innovative approach to pharmacy services through technology. The company's self-service kiosks and remote pharmacist model aimed to improve convenience and access to medications. However, with a negative profit margin of -106.2%, a negative ROE of -194.7%, and a debt-to-equity ratio of 9.82, the company's financial health was a significant concern. The company's beta of -134.43 suggests an inverse correlation with the market, but this is less relevant given its bankruptcy filing. The Chapter 7 liquidation filing on February 2, 2024, represents a critical event, rendering the stock essentially worthless.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market capitalization of $0.00B, reflecting the company's distressed financial state and Chapter 7 liquidation.
- Profit margin of -106.2%, indicating significant losses relative to revenue.
- Gross margin of 5.2%, suggesting limited profitability even before considering operating expenses.
- Return on Equity (ROE) of -194.7%, highlighting the company's inability to generate profits from shareholder equity.
- Debt-to-Equity ratio of 9.82, signaling a high level of financial leverage.
Competidores y Pares
Fortalezas
- Innovative self-service pharmacy kiosk technology.
- Remote pharmacist consultation capabilities.
- Potential for improved medication access and adherence.
- Strategic partnerships with medical clinics and retail locations.
Debilidades
- High capital expenditure for kiosk deployment.
- Regulatory hurdles and licensing requirements.
- Limited brand recognition and market share.
- Dependence on partnerships for kiosk placement.
Catalizadores
- Ongoing: Bankruptcy proceedings and asset liquidation.
Riesgos
- Ongoing: Complete loss of investment due to liquidation.
- Potential: Legal challenges or claims arising from the bankruptcy proceedings.
- Potential: Delisting from the OTC market.
Oportunidades de crecimiento
- Expansion of MedAvail MedCenters into Underserved Areas: MedAvail could have explored expanding its MedCenter kiosks into rural or underserved areas where access to traditional pharmacies is limited. This could have been achieved through partnerships with community health centers or mobile healthcare providers. The market size for rural healthcare is substantial, with ongoing efforts to improve access through telehealth and remote services. Timeline: 2-3 years for significant expansion.
- Integration with Telehealth Platforms: Integrating MedAvail's services with existing telehealth platforms could have provided a seamless experience for patients seeking remote consultations and prescription fulfillment. This would have required developing APIs and partnerships with telehealth providers. The telehealth market is projected to reach $55 billion by 2027, presenting a significant opportunity. Timeline: 1-2 years for initial integration.
- Partnerships with Employer-Sponsored Health Clinics: Collaborating with employers to install MedAvail MedCenters in on-site health clinics could have provided employees with convenient access to medications and pharmacist consultations. This would have required targeting large employers with a focus on employee wellness programs. The employer-sponsored health market is growing, driven by efforts to reduce healthcare costs and improve employee health. Timeline: 1-2 years for pilot programs.
- Development of a Mobile Pharmacy App: Creating a mobile app that allows patients to manage prescriptions, consult with pharmacists, and locate MedAvail MedCenters could have enhanced the company's digital presence and improved patient engagement. This would have required investing in app development and marketing. The mobile health market is expanding rapidly, with increasing adoption of digital health solutions. Timeline: 6-12 months for initial app launch.
- Expansion into Canada: Expanding its kiosk network into Canada could have provided access to a new market. This would have required navigating Canadian healthcare regulations and establishing partnerships with Canadian healthcare providers. The Canadian pharmacy retail market is substantial, with a growing demand for convenient and accessible pharmacy services. Timeline: 2-3 years for initial expansion.
Oportunidades
- Expansion into underserved areas with limited pharmacy access.
- Integration with telehealth platforms and remote patient monitoring systems.
- Partnerships with employer-sponsored health clinics.
- Development of a mobile pharmacy app for enhanced patient engagement.
Amenazas
- Competition from established pharmacy chains and online pharmacies.
- Changes in healthcare regulations and reimbursement policies.
- Technological obsolescence and the emergence of new pharmacy solutions.
- Cybersecurity risks and data privacy concerns.
Ventajas competitivas
- Proprietary MedAvail MedCenter technology.
- Established network of partnerships with medical clinics, retail stores, and employer sites.
- First-mover advantage in the self-service pharmacy kiosk market.
- Integration of remote pharmacist consultations with on-site dispensing.
Acerca de MDVLQ
MedAvail Holdings, Inc. was established as a technology-enabled retail pharmacy company focused on developing and commercializing innovative self-service pharmacy solutions. The company's core offering was the MedAvail MedCenter, a self-service kiosk designed for deployment in medical clinics, retail locations, employer sites, and other convenient locations. These kiosks provided patients with on-site access to prescription medications, facilitated by a live audiovisual connection to a remote pharmacist. This allowed for real-time supervision and counseling during the dispensing process. MedAvail aimed to improve medication access and adherence by offering a convenient and efficient alternative to traditional pharmacies. The company's solutions were available in the United States and Canada. However, on February 2, 2024, MedAvail Holdings, Inc. and its affiliates filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware, marking the end of its operations.
Qué hacen
- Developed and commercialized self-service pharmacy kiosks (MedAvail MedCenters).
- Offered on-site prescription dispensing in various locations.
- Established audiovisual connections to live pharmacists for remote consultations.
- Provided a mobile application for managing prescriptions.
- Aimed to improve medication access and adherence.
- Served patients in the United States and Canada.
Modelo de Negocio
- Generated revenue through the dispensing of prescription medications via its MedAvail MedCenters.
- Charged fees for pharmacist consultations and related services.
- Established partnerships with medical clinics, retail stores, and employer sites to host MedAvail MedCenters.
- Focused on improving medication access and adherence for patients.
Contexto de la Industria
MedAvail Holdings, Inc. operated within the pharmaceutical retail industry, which is characterized by increasing demand for convenient and accessible healthcare services. The industry is dominated by large pharmacy chains and faces competition from online pharmacies and mail-order services. MedAvail attempted to carve out a niche by offering self-service kiosks and remote pharmacist consultations. However, the company's bankruptcy filing indicates the challenges of competing in this landscape, particularly with a capital-intensive business model and the need to establish partnerships with healthcare providers and retail locations.
Clientes Clave
- Patients seeking convenient access to prescription medications.
- Medical clinics and healthcare providers looking to offer on-site pharmacy services.
- Retail stores and employer sites seeking to enhance customer and employee benefits.
- Individuals in the United States and Canada.
Finanzas
Gráfico e información
Precio de la acción de MedAvail Holdings, Inc. (MDVLQ): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para MDVLQ.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para MDVLQ.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para MDVLQ.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de MDVLQ en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Competidores y Pares
Información del mercado OTC de MDVLQ
The OTC Other tier represents the lowest tier of the OTC market, indicating that MedAvail Holdings, Inc. did not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may be distressed, bankrupt, or unwilling to provide audited financial statements. Trading on the OTC Other tier carries significant risks due to the lack of regulatory oversight and transparency compared to exchanges like the NYSE or NASDAQ.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure and transparency.
- High risk of fraud and manipulation.
- Potential for delisting and loss of investment.
- Significant price volatility and illiquidity.
- Bankruptcy and liquidation risk.
- Verify the company's legal status and registration.
- Review any available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Be aware of the potential for fraud and manipulation.
- Presence of a functional website (if available).
- Any available news coverage or press releases (if any).
- Information on the company's management team (if available).
- Verification of the company's registration with regulatory authorities (if possible).
Preguntas Comunes Sobre MDVLQ
¿Cuáles son los factores clave para evaluar MDVLQ?
MedAvail Holdings, Inc. (MDVLQ) actualmente tiene una puntuación IA de 50/100, indicando puntuación moderada. Fortaleza clave: Innovative self-service pharmacy kiosk technology.. Riesgo principal a monitorear: Ongoing: Complete loss of investment due to liquidation.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de MDVLQ?
MDVLQ actualmente puntúa 50/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de MDVLQ?
Los precios de MDVLQ se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre MDVLQ?
La cobertura de analistas para MDVLQ incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en MDVLQ?
Las categorías de riesgo para MDVLQ incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Complete loss of investment due to liquidation.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de MDVLQ?
La relación P/E para MDVLQ compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está MDVLQ sobrevalorada o infravalorada?
Determinar si MedAvail Holdings, Inc. (MDVLQ) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de MDVLQ?
MedAvail Holdings, Inc. (MDVLQ) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Information is based on publicly available data and news reports.
- The company has filed for Chapter 7 liquidation, which significantly impacts its financial viability and stock value.